论文部分内容阅读
１５例格体－巴利综合征（ＧＢＳ）患者于发病后７～４９天（平均１２天）接受静脉大剂量免疫球蛋白（ＩＶＩｇ）治疗，０．４ｇ／ｋｇ／天，５天为一疗程。１３例于治疗后３～１７天（平均７天）临床症状改善，２例恶化，未发现严重不良反应，我们认为ＩＶＩｇ治疗ＧＢＳ有效。
Fifteen patients with GBS were treated with intravenous high-dose immunoglobulin (IVIg) 7 to 49 days (mean, 12 days) after onset, at 0.4 g / kg / day for 5 days . Thirteen patients showed improvement in clinical symptoms 3 to 17 days after treatment (average 7 days), two patients deteriorated and no serious adverse reactions were found. We think IVIg is effective in treating GBS.